[go: up one dir, main page]

NL8100292A - Zuur additiezout van m-amsa; samenstelling die dit zout bevat; werkwijze voor de bereiding van het zout en de samenstelling; farmaceutisch preparaat met anti-tumorwerking. - Google Patents

Zuur additiezout van m-amsa; samenstelling die dit zout bevat; werkwijze voor de bereiding van het zout en de samenstelling; farmaceutisch preparaat met anti-tumorwerking. Download PDF

Info

Publication number
NL8100292A
NL8100292A NL8100292A NL8100292A NL8100292A NL 8100292 A NL8100292 A NL 8100292A NL 8100292 A NL8100292 A NL 8100292A NL 8100292 A NL8100292 A NL 8100292A NL 8100292 A NL8100292 A NL 8100292A
Authority
NL
Netherlands
Prior art keywords
amsa
organic acid
composition
gluconolactone
salt
Prior art date
Application number
NL8100292A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26812557&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL8100292(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL8100292A publication Critical patent/NL8100292A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8100292A 1980-01-24 1981-01-21 Zuur additiezout van m-amsa; samenstelling die dit zout bevat; werkwijze voor de bereiding van het zout en de samenstelling; farmaceutisch preparaat met anti-tumorwerking. NL8100292A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11480980A 1980-01-24 1980-01-24
US11480980 1980-01-24
US06/194,350 US4322424A (en) 1980-01-24 1980-10-17 Crystalline glucoconate salt of m-AMSA and compositions containing same
US19435080 1980-10-17

Publications (1)

Publication Number Publication Date
NL8100292A true NL8100292A (nl) 1981-08-17

Family

ID=26812557

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8100292A NL8100292A (nl) 1980-01-24 1981-01-21 Zuur additiezout van m-amsa; samenstelling die dit zout bevat; werkwijze voor de bereiding van het zout en de samenstelling; farmaceutisch preparaat met anti-tumorwerking.

Country Status (17)

Country Link
US (1) US4322424A (sv)
AT (1) AT380474B (sv)
AU (1) AU543758B2 (sv)
CA (1) CA1252103A (sv)
CH (1) CH648023A5 (sv)
DE (1) DE3102026A1 (sv)
DK (1) DK29781A (sv)
FI (1) FI79840C (sv)
FR (1) FR2474493B1 (sv)
GB (1) GB2068729B (sv)
GR (1) GR82326B (sv)
IE (1) IE50884B1 (sv)
IT (1) IT1170638B (sv)
LU (1) LU83081A1 (sv)
NL (1) NL8100292A (sv)
SE (1) SE453497B (sv)
YU (1) YU42552B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU186383B (en) * 1981-02-27 1985-07-29 Biogal Gyogyszergyar Process for producing new citostatic amni-acridie-alpha, beta-bracket-d-bracket closed, or aracket-l-bracket closed-n-glycoside derivatives and salts
US4575509A (en) * 1983-01-31 1986-03-11 Bristol-Myers Company Water-soluble formulations of m-AMSA with pyroglutamic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1674923A (en) * 1924-04-12 1928-06-26 Schnorf Carl Process for the production of carbohydrate-acridine compounds and solutions thereof
US3839344A (en) * 1973-03-28 1974-10-01 Schering Corp N-methyl d-glucamine salt of 2(2'-methyl-3'-trifluoromethylanilino)nicotinic acid
US4258191A (en) * 1979-03-29 1981-03-24 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Multi-step process for the production of methanesulfon-m-anisidide, 4'-(9-acridinylamino)-
ZA805652B (en) * 1979-09-14 1981-09-30 New Zealand Dev Finance Compounds having antitumour properties
ZA811304B (en) * 1980-03-11 1982-06-30 Warner Lambert Co Pharmaceutical salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide

Also Published As

Publication number Publication date
AU543758B2 (en) 1985-05-02
DE3102026C2 (sv) 1990-05-31
GR82326B (sv) 1984-12-13
IE50884B1 (en) 1986-08-06
FI79840C (sv) 1990-03-12
FR2474493B1 (fr) 1985-12-13
IE810119L (en) 1981-07-24
GB2068729A (en) 1981-08-19
IT8147604A1 (it) 1982-07-21
US4322424A (en) 1982-03-30
AU6651281A (en) 1981-07-30
CA1252103A (en) 1989-04-04
FI79840B (fi) 1989-11-30
SE8100341L (sv) 1981-07-25
DK29781A (da) 1981-07-25
GB2068729B (en) 1983-10-19
FI810180L (fi) 1981-07-25
LU83081A1 (fr) 1981-09-10
ATA32681A (de) 1985-10-15
YU14581A (en) 1983-06-30
SE453497B (sv) 1988-02-08
AT380474B (de) 1986-05-26
CH648023A5 (de) 1985-02-28
FR2474493A1 (fr) 1981-07-31
YU42552B (en) 1988-10-31
DE3102026A1 (de) 1982-03-04
IT8147604A0 (it) 1981-01-21
IT1170638B (it) 1987-06-03

Similar Documents

Publication Publication Date Title
KR100744917B1 (ko) 신규한 결정형의Ｎ-[4-[2-(2-아미노-4,7-디히드로-4-옥소-3Ｈ-피롤로[2,3-ｄ]피리미딘-5-일)에틸]벤조일]-Ｌ-글루탐산 및 이의 제조방법
US10253031B2 (en) Stable pemetrexed arginine salt and compositions comprising it
US20160143911A1 (en) Stable and water soluble pharmaceutical compositions comprising pemetrexed
JP6942182B2 (ja) カルグルミン酸を含有する非経口的薬剤配合物
US4360523A (en) Pharmaceutical formulations of 4'-(9-acridinylamino)-methanesulfon-m-anisidide
CA1307464C (en) Lyophilized or precipitated cephalosporin zwitterion and salt composition
NL8100292A (nl) Zuur additiezout van m-amsa; samenstelling die dit zout bevat; werkwijze voor de bereiding van het zout en de samenstelling; farmaceutisch preparaat met anti-tumorwerking.
EP3369816B1 (en) Composition stably containing single-stranded nucleic acid molecule that suppresses expression of tgf-beta1 gene
JPH10502616A (ja) Ｄｘ−５２−１化合物の安定化法及びその凍結乾燥組成物
JPH0343251B2 (sv)
CA1159368A (en) Antitumor compositions
WO2001076603A1 (fr) Compositions medicamenteuses contenant un derive de camptothecine et un agent de regulation de ph
US4425348A (en) Antitumor compositions
EP1740214B1 (en) Method of stabilizing disordered cefovecin sodium salt
US4575509A (en) Water-soluble formulations of m-AMSA with pyroglutamic acid
NL8803126A (nl) Waterige preparaten die een piperidinylcyclopentylhepteenzuurderivaat bevatten.
JPH032862B2 (sv)
NL8006440A (nl) Verbindingen en preparaten met anti-tumorwerking; werkwijze voor het bereiden daarvan.
KR810002136B1 (ko) 아목시실린 나트륨 함유 주사용 약제조성물의 제조방법
HU198395B (en) Process for production of liofilized compositions containing complexes of increasing heart activity antiphosphodiestrase and in water soluable vitamins and medical compositions containing such active substances
JPS6348877B2 (sv)
WIRKSTOFFEN et al. TEMOZOLOMIDE, PROCESSES OF MAKING AND USING THE SAME
EP1791528A1 (de) Lyophilisat enthaltend n-diaminomethylen-2-methyl-4,5-di-(methylsulfonyl)-benzamid

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

BV The patent application has lapsed